Skip to content

Clovis Oncology, Inc.

Delisted

CIK 1466301fmd_12XBJ6R7XR7JEYPMG1PPYJTR3NManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2010 to Sep 30, 2022, 48 periods

Latest annual · FY2021

Millions
Total revenues
149
Gross profit
0
Operating income
(226)
Net income
(265)
Free cash flow
(196)

Latest quarter · Q3 FY2022

Millions
Total revenues
31
Operating income
(44)
Net income
(56)
Free cash flow
(41)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2018 to FY2021
+16.0%
Revenue, 5 yearsFY2016 to FY2021
+353.0%
Net income, 5 yearsFY2016 to FY2021
n/m

Clovis Oncology, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2021FY2020ChangeSource
Revenue$148.8 million$164.5 million-9.6%10-K 2022-02-24 · proof
Operating income-$225.8 million-$302.2 million10-K 2022-02-24 · proof
Net income-$264.5 million-$369.2 million10-K 2022-02-24 · proof
Cash from operating activities-$196.1 million-$252.7 million10-K 2022-02-24 · proof
Free cash flow-$196.4 million-$253.1 million10-K 2022-02-24 · proof
Total assets$472.8 million$605.6 million-21.9%10-K 2022-02-24 · proof
Total liabilities$751.7 million$764.3 million-1.7%10-K 2022-02-24 · proof
Cash and cash equivalents$143.4 million$240.2 million-40.3%10-K 2022-02-24 · proof
What was Clovis Oncology, Inc.'s revenue in fiscal 2021?
Clovis Oncology, Inc. reported revenue of $148.8 million for fiscal 2021 (the year ended Dec 31, 2021), against $164.5 million the year before (-9.6%). Source: the 10-K filed with the SEC on Feb 24, 2022. SEC
What was Clovis Oncology, Inc.'s operating income in fiscal 2021?
Clovis Oncology, Inc. reported operating income of -$225.8 million for fiscal 2021 (the year ended Dec 31, 2021), against -$302.2 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2022. SEC
What was Clovis Oncology, Inc.'s net income in fiscal 2021?
Clovis Oncology, Inc. reported net income of -$264.5 million for fiscal 2021 (the year ended Dec 31, 2021), against -$369.2 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2022. SEC
What was Clovis Oncology, Inc.'s cash from operating activities in fiscal 2021?
Clovis Oncology, Inc. reported cash from operating activities of -$196.1 million for fiscal 2021 (the year ended Dec 31, 2021), against -$252.7 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2022. SEC
What was Clovis Oncology, Inc.'s free cash flow in fiscal 2021?
Clovis Oncology, Inc. reported free cash flow of -$196.4 million for fiscal 2021 (the year ended Dec 31, 2021), against -$253.1 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2022. SEC
What are Clovis Oncology, Inc.'s total assets?
As of Dec 31, 2021, Clovis Oncology, Inc. reported total assets of $472.8 million, against $605.6 million a year earlier (-21.9%). Source: the 10-K filed with the SEC on Feb 24, 2022. SEC
What are Clovis Oncology, Inc.'s total liabilities?
As of Dec 31, 2021, Clovis Oncology, Inc. reported total liabilities of $751.7 million, against $764.3 million a year earlier (-1.7%). Source: the 10-K filed with the SEC on Feb 24, 2022. SEC
What are Clovis Oncology, Inc.'s cash and cash equivalents?
As of Dec 31, 2021, Clovis Oncology, Inc. reported cash and cash equivalents of $143.4 million, against $240.2 million a year earlier (-40.3%). Source: the 10-K filed with the SEC on Feb 24, 2022. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1466301&period_type=annual&limit=5"

Information only, not investment advice.